Chimeric antigen receptor T cells (also known as CAR T cells) are T cells that have been genetically engineered to produce an artificial T-cell receptor for use in immunotherapy.
Chimeric antigen receptors (CARs, also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors) are receptor proteins that have been engineered to give T cells the new ability to target a specific protein. The receptors are chimeric because they combine both antigen-binding and T-cell activating functions into a single receptor
Prasad Research Foundation with the help of many international collaborations of repute is developing modalities and the protocol using CAR to work with different conditions on Oncology.
We are developing CAR models which has cost efficiency as the unique differentiator.
For your patients who are suffering from acute oncology conditions, please call us in discussing the best options for your patient.